U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT06984822) titled 'Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant' on May 05.
Brief Summary: This study aims to investigate the association between serum biomarkers and clinical response to anti-VEGF or dexamethasone implant by assessing OCT-biomarkers in patients with diabetic macular edema, DME, and to compare these with a group of naive patients (those not previously treated for DME).
Study Start Date: Aug. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Diabetic Macular Edema
Visual Impairment
Diabetes Mellitus
Hyperglycaemia (Diabetic)
Oxidative Stress
Vascular Endothelial Growth Fac...